Gupta Rishi 4
4 · Enliven Therapeutics, Inc. · Filed Feb 17, 2026
Research Summary
AI-generated summary of this filing
Enliven (ELVN) Director Rishi Gupta Receives Stock Awards
What Happened
Rishi Gupta, a non-employee director of Enliven Therapeutics (ELVN), was granted two derivative awards on February 12, 2026: 33,989 shares and 1,580 shares (total 35,569 shares) shown at $0.00 per share in the Form 4. These were reported as grants/awards (transaction code A) rather than purchases or sales — i.e., compensation-style awards that will vest over time rather than immediate cash transactions.
Key Details
- Transaction date: 2026-02-12; Form 4 filed 2026-02-17 (timely — within required business days).
- Awards: 33,989 shares @ $0.00 and 1,580 shares @ $0.00 (total 35,569 shares).
- Shares owned after transaction: Not disclosed in the provided filing excerpt.
- Transaction code: A (Grant/Award).
- Footnotes:
- F1: For the larger award, 1/36th vests on Feb 2, 2026 and monthly thereafter, subject to continued service as a non-employee director.
- F2: For the smaller award, 100% vests on the earlier of the first anniversary of the 2026 annual meeting or the date of the 2027 annual meeting, subject to continued service.
Context
These grants are compensation awards for a director and are not sales or purchases that directly reveal market sentiment. They appear to be time-based derivative awards (vesting schedules noted), not exercises or cashless sales. For retail investors, such grants are common for board service and should be viewed as compensation rather than an immediate bet on the stock price.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-02-12+33,989→ 33,989 totalExercise: $27.16Exp: 2036-02-12→ Common Stock (33,989 underlying) - Award
Stock Option (right to buy)
[F2]2026-02-12+1,580→ 1,580 totalExercise: $27.16Exp: 2036-02-12→ Common Stock (1,580 underlying)
Footnotes (2)
- [F1]1/36th of the shares subject to the option vest on February 2, 2026 and each month thereafter, subject to the Reporting Person continuing as a non-employee director through the applicable vesting date.
- [F2]100% of the shares subject to the option will vest on the earlier of (i) the first anniversary of the 2026 annual meeting of the Issuer's stockholders or (ii) the date of the 2027 annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing as a non-employee director through the applicable vesting date.